Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

VPS52 Inhibitors

VPS52 inhibitors are a class of chemical compounds designed to specifically target and inhibit the activity of the VPS52 (Vacuolar Protein Sorting 52) protein, a key component of the Golgi-associated retrograde protein (GARP) complex. VPS52 is involved in vesicular trafficking, particularly in the retrograde transport of proteins from endosomes to the trans-Golgi network (TGN). The GARP complex, which includes VPS52 along with other subunits such as VPS53 and VPS54, plays an essential role in maintaining the proper sorting and recycling of proteins, ensuring that they reach their correct intracellular destinations. By inhibiting VPS52, these compounds interfere with the function of the GARP complex, disrupting intracellular trafficking pathways and protein recycling processes that are critical for cellular homeostasis and organelle function.

The mechanism of action for VPS52 inhibitors typically involves binding to functional regions of the protein that are necessary for its interaction with other GARP complex components or its engagement with vesicular membranes. This inhibition impairs the complex's ability to mediate retrograde transport, resulting in disruptions in the flow of proteins between the endosomes and the Golgi apparatus. Such interference can affect a variety of cellular processes, including membrane protein recycling, lysosome function, and the maintenance of Golgi structure. Researchers use VPS52 inhibitors to study the specific roles of VPS52 in vesicle trafficking and to explore how alterations in this pathway influence broader aspects of cellular organization and function. These inhibitors provide insights into the molecular mechanisms governing intracellular transport and highlight the critical role of protein sorting systems in maintaining the dynamic balance of cellular processes across various compartments.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

May alter lysosomal function, indirectly affecting VPS52-associated processes.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Could disrupt Golgi apparatus function, indirectly influencing VPS52 activity.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Might alter Golgi and endosomal compartments, affecting VPS52 function.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Could inhibit N-linked glycosylation, affecting proteins interacting with VPS52.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Might disrupt microtubule dynamics, affecting VPS52-related transport processes.

Colchicine

64-86-8sc-203005
sc-203005A
sc-203005B
sc-203005C
sc-203005D
sc-203005E
1 g
5 g
50 g
100 g
500 g
1 kg
$100.00
$321.00
$2289.00
$4484.00
$18207.00
$34749.00
3
(2)

Could affect microtubule polymerization, influencing VPS52-related activities.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Might inhibit dynamin, affecting endocytic pathways involving VPS52.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Could disrupt actin filaments, influencing cellular processes involving VPS52.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

Could inhibit vacuolar-type H+-ATPase, affecting lysosomal function involving VPS52.

Concanamycin B

81552-33-2sc-221434
sc-221434A
100 µg
500 µg
$463.00
$1569.00
2
(0)

Might inhibit vacuolar-type H+-ATPase, affecting VPS52-related processes.